Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial

IMPORTANCE: A lower dose of intravenous alteplase appears to be a safer treatment option than the standard dose, reducing the risk of symptomatic intracerebral hemorrhage. There is uncertainty, however, over how this effect translates into an overall clinical benefit for patients with acute ischemic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Neurol
Main Authors: Wang, Xia, Robinson, Thompson G., Lee, Tsong-Hai, Li, Qiang, Arima, Hisatomi, Bath, Philip M., Billot, Laurent, Broderick, Joseph, Demchuk, Andrew M., Donnan, Geoffrey, Kim, Jong S., Lavados, Pablo, Lindley, Richard I., Martins, Sheila O., Olavarria, Veronica V., Pandian, Jeyaraj D., Parsons, Mark W., Pontes-Neto, Octavio M., Ricci, Stefano, Sharma, Vijay K., Thang, Nguyen H., Wang, Ji-Guang, Woodward, Mark, Anderson, Craig S., Chalmers, John
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5822216/
https://ncbi.nlm.nih.gov/pubmed/28973174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2017.2286
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados